Ozempic side effects

Learn about the common and severe Ozempic (semaglutide) side effects. Learn about safety information, warnings, & when to seek medical attention.

From Ozempic burps to diarrhea and hair loss, we've got all the gory details on semaglutide (Ozempic) side effects.

A brief introduction to Ozempic, its primary uses, and the potential side effects, especially related to mental health. Discover more on our latest blog post.

Side effects range from mild to severe—here’s what to know.

There are serious GI side effects of Ozempic, including nausea, diarrhea, and more. Learn what this drug does to your body and how to manage side effects.

Despite their undeniable slimming effects, injections of semaglutide - branded as Ozempic and Wegovy - have been linked to a catalogue of side effects from the embarrassing to potentially life-threatening.

This post was adapted from episode 33 of the Nourished & Free™ podcast: “Dietitian Review of GLP-1 Drugs for Weight Loss and what NO ONE is telling you!” Listen to the full episode. Special thanks to Dr. Idz for discussing this topic with me! If you haven’t heard about Ozempic, Wegovy, or Mounjaro by now […]

Combatting Ozempic Hair Loss: Causes and Solutions · Ozempic Hair Loss: Effects, Causes, and Solutions Lately, there's been a lot more talk about Ozempic and the side effects that come with it. A big worry for many is hair loss - people are wondering if this popular medication, specifically the semaglutide medication O

Wegovy and Ozempic also known as semaglutide are medications that have gained a lot of attention in recent years due to their effectiveness in helping people lose weight. We discuss the most common side effects associated with Wegovy and provide tips on how to minimize them without using medication. Whether you are considering taking Wegovy or are already using it, this post will provide you with valuable information to help you make informed decisions about your weight loss journey.

In the August edition of the Annals of Emergency Medicine, Dr. William Dixon from the Department of Emergency Medicine at Stanford Health Care, raised concerns about the risk of gastroparesis, or stomach paralysis, among patients taking a new class of medications known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which include the blockbuster treatments Ozempic, Wegovy, Mounjaro, and Zepbound.